We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Urine-Based Immunoassays Developed for Visceral Leishmaniasis

By LabMedica International staff writers
Posted on 04 Nov 2016
Visceral Leishmaniasis (VL), a severe parasitic disease, and can be fatal if diagnosis and treatment is delayed and diagnostic tests available for VL such as tissue aspiration are invasive and painful although they are capable of evaluating the treatment response.

Post kala-azar dermal leishmaniasis (PKDL), a skin related outcome, is a potential reservoir for the spread of VL and parasitological examination of slit-skin smear along with the clinical symptoms is routinely used for diagnosis of PKDL. More...
Therefore, a noninvasive test with acceptable sensitivity and competency, additionally, to decide cure would be an asset in disease management and control.

Infectious disease specialists at the Indian Institute of Chemical Biology (Kolkata, India) enrolled 186 participants during March 2011 to July 2016. Urine samples of 97 parasitologically proven and rK39-RDT tested VL cases were obtained before the treatment started. Out of 97 VL samples, 18 were acquired for longitudinal study at different time points. Samples were also collected from 75 control subjects and 14 urine samples, which were confirmed by skin biopsy or slit-skin smear were collected from PKDL patients.

The team also performed enzyme-linked immunosorbent assays (ELISA) and the optical densities were read at 492 nm. The scientists also carried out dot blot assays and a nitrocellulose membrane-based dipstick was prepared to have a test and a control line for visual detection of the disease. Like dot blot assay the dipstick test comprises incubation with urine sample followed by enzyme-conjugated anti-human immunoglobulin G (IgG) and then substrate chromogen including washing in each step. Dark brown colored bands both at the test and control line show VL positivity and a single band at the control line infers VL negativity.

The team found that the ELISA and dipstick test were extremely effective for diagnosis of VL and PKDL through urine samples thus, may substitute the existing invasive diagnostics. Utility of these tests as indirect methods of monitoring parasite clearance can define infected versus cured. Urine-based dipstick test is simple, sensitive and above all noninvasive method that may help not only in active VL case detection but also to ascertain treatment response. It can therefore, be deployed widely for interventions in disease management of VL particularly in poor resource settings. The study was published on October 14, 2016, in the journal Public Library of Science Neglected tropical Diseases.

Related Links:
Indian Institute of Chemical Biology



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Automated PCR Setup
ESTREAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The new RABTA sets a high standard in laboratory diagnostics (Photo courtesy of Randox)

Pioneering Analyzer with Advanced Biochip Technology Sets New Standard in Lab Diagnostics

A state-of-the-art analyzer combines advanced technology with exceptional efficiency to meet the demanding needs of modern laboratories. Randox Toxicology (Antrim, Ireland) has launched its pioneering... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.